Chakraborty R, Sharma D, Kapoor DU, Dwivedi A, Khabiya R, Sen S. Implications of metabolic dysfunction associated fatty liver disease in COVID-19. World J Clin Cases 2023; 11(6): 1275-1286 [DOI: 10.12998/wjcc.v11.i6.1275][Reference Citation Analysis]
2
Kamiya A, Ida K. Liver Injury and Cell Survival in Non-Alcoholic Steatohepatitis Regulated by Sex-Based Difference through B Cell Lymphoma 6. Cells 2022;11. [PMID: 36497010 DOI: 10.3390/cells11233751][Reference Citation Analysis]
3
Fang J, Yu C, Li X, Yao J, Fang Z, Yoon S, Yu W. Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.997018][Reference Citation Analysis]